Immunodeficiencies LO2

Definition: Primary immunodeficiency refers to a diverse group of disorders caused by intrinsic defects in the immune system, often involving genetic mutations.
Objective: To explore how genetic mutations lead to diverse clinical outcomes in patients with primary immunodeficiency.
Key Questions: Why are the clinical manifestations in primary immunodeficiency so variable?

Each patient has a distinct set of genes, affecting immune system functionality.
Genes do not operate in isolation; instead, they interact with surrounding genes that may also regulate the immune response pathways.
Illustration: The penetrance of IgA deficiency highlights how different genetic backgrounds influence clinical outcomes:
- Selective IgA Deficiency:
- Most common immunodeficiency; defined by the inability to produce the mucosal antibody, IgA.
- Expected outcome includes susceptibility to mucosal infections and recurrent gastrointestinal or respiratory infections.
- Secretory IgA acts as a non-inflammatory antibody; its absence can lead to inflammatory responses resulting in conditions like inflammatory bowel disease, celiac disease, and autoimmunity.
- Clinical Variability:
- Approximately 30% of patients with IgA deficiency exhibit expected symptoms, while 70% are asymptomatic, indicating unexplained penetrance variability.
- Hypothesis: Asymptomatic patients may compensate for the absence of IgA by transporting other antibody classes to mucosal sites, though this theory remains not fully understood.

Importance of Protein Sequence and Structure:
- A defect in Gene X presents differently from a defect in Gene Y.
- The clinical outcome is dependent on:
- The particular protein produced by the gene.
- Where in the immune system the gene or protein is expressed.
Immune System Response:
- Humoral Immunity: Critical for combating extracellular microbes (bacteria, fungi, protozoa), primarily through antibodies and complement.
- Cell-mediated Immunity: T cells play a vital role in fighting intracellular microorganisms (viruses, intracellular bacteria).
Clinical Implications:
- Mutations impacting B cell functions lead to increased susceptibility to extracellular bacteria.
- Mutations affecting cytotoxic T cells lead to greater vulnerability to viral infections.
- For example, defects in the Th1 pathway correlate with susceptibility to intracellular pathogens, whereas deficiencies in the Th17 pathway can lead to susceptibility to extracellular microbes.

Different mutations yield various clinical manifestations:
- Point Mutations: Minor alterations in the genetic sequence may only slightly affect the corresponding protein's function.
- Deletions and Insertions: These generally cause a frameshift in the reading frame, potentially resulting in truncated or ablated protein synthesis, usually leading to more severe consequences.
- Mutations in Regulatory Regions: Can lead to changes in protein expression levels without affecting the protein structure itself.
- Example: Mutations in the STAT1 signaling molecule have shown complexity, including recessive mutations and rare gain-of-function mutations.

B Cell Deficiencies:
- Characterized by reduced immunoglobulin levels and lack of germinal centers in lymphoid organs, leading to recurrent pyogenic bacterial infections (pus-forming bacteria).
T Cell Deficiencies:
- Patients with these deficiencies experience repeated infections by viruses, intracellular bacteria, and associated malignancies (e.g., Epstein-Barr virus and Kaposi's sarcoma).
Innate Immune System Deficiencies:
- Tend to be highly variable in clinical manifestations; can result in different infection types.

Different immunodeficiencies result in susceptibility to various pathogens.
The complexity of genetics, molecular function, and type of mutations contributes to the variability observed in clinical manifestations of primary immunodeficiencies.
Looking ahead: upcoming learning outcomes will focus on specific diseases related to primary immunodeficiencies and their clinical presentations.